• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. LXC13; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. LXC13; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number LXC13
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Not Applicable (3189); No Code Available (3191)
Event Date 03/30/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).The dhr for lot 4516 was reviewed.No ncs, reworks, or defects were found.Diagnosed with gerd defined by abnormal ph testing: yes.Chronic gerd symptoms despite maximum medical therapy for treatment of reflux: yes.Ph test performed (b)(6) 2013.Date ppi stopped (b)(6) 2013.Method used: bravo capsule.Duration of test: 48 hours.Test duration: 1 day, 23 hours, 51 minutes.How long has the patient had gerd? 5 years.How long has the patient been taking ppis? 7 months.Demeester score components: day 1 day 2 total: total time ph<4 (enter with 1 place after decimal i.E.5.7%) 6.3 % 12.4 % 9.4 %, upright time ph<4 (enter with 1 place after decimal i.E.5.7%) 6.2 % 19.7 % 14.3 %, supine time ph<4 (enter with 1 place after decimal i.E.5.7%) 4 % 0 % 2.2 %, total number of reflux episodes (enter to nearest whole number) 39 101 139, number of reflux episodes >5 min (enter to nearest whole number) 7 10 17, longest reflux episode (enter to nearest whole number) 14 minutes 23 minutes 23 minutes.Comments: patient has been having pain in abdominal area, a burning sensation, for 5 years.He thought it was related to an abdominal wall hernia and was told that ranitidine might help the symptom.He became aware of severe gerd symptoms about 8 months ago.60 month f/u ¿ (b)(6) 2019.Date test performed: (b)(6) 2019.Date of last ppi dose: (b)(6) 2014.Method used: bravo capsule.Test duration: 48 hours (2 days).Within the last 30 days did the patient take ppi medications? no.Within the last 30 days did the patient take h2 blockers? no.Within the last 30 days did the patient take antacids? no.Demeester score components: day 1 day 2 total: total time ph<4 (enter with 1 place after decimal i.E.5.7%) 3.1 % 6.5 % 4.9 %, upright time ph<4 (enter with 1 place after decimal i.E.5.7%) 5.6 % 10.4 % 8.2 %, supine time ph<4 (enter with 1 place after decimal i.E.5.7%) 0.0 % 0.6 % 0.3 %, total number of reflux episodes 16 51 67, number of reflux episodes >5 min 2 3 5, longest reflux episode (enter to nearest whole number) 13 minutes 9 minutes 13 minutes.Patient seen in clinic for follow-up after testing and treatment (dilation) at outside hospital.All symptoms resolved.Will progress with study schedule.
 
Event Description
It was reported that post implant (post approval study subject), patient reports sharp pain in the epigastric region.The subject went to the er and was subsequently admitted.Subject reported having an x-ray, ultrasound, egd and later an egd with dilation (completed april 12 at (b)(6) medical center).
 
Manufacturer Narrative
(b)(4).Corrected date: event month/day/year updated to (b)(6) 2019 based on additional information received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LXC13
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
MDR Report Key8607956
MDR Text Key145089930
Report Number3008766073-2019-00343
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005141
UDI-Public00855106005141
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 05/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/18/2017
Device Catalogue NumberLXC13
Device Lot Number4516
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/02/2019
Initial Date FDA Received05/14/2019
Supplement Dates Manufacturer Received06/03/2019
Supplement Dates FDA Received06/04/2019
Patient Sequence Number1
Patient Age42 YR
Patient Weight73
-
-